Applied DNA shoots, scores on multiple COVID fronts
By GREGORY ZELLER // It’s been a big week for one of Long Island’s boldest biotechs. Applied DNA Sciences, a Stony Brook-based leader in polymerase chain reaction-based DNA manufacturing, has earned New York State approvals for the veterinary trial of a COVID-19 vaccine candidate developed in conjunction with Italian startup EvviVax, a spinoff of frequent Applied DNA partner Takis Biotech. The Stony Brook biotech – which focused primarily on DNA-based supply-chain authentication before its 2015 acquisition…